Prdm9 - PR/SET domain 9 Gene
Also Known as Prdm7
Species: Rattus norvegicus
Summary
Predicted to enable DNA binding activity; histone-lysine N-methyltransferase activity; and protein homodimerization activity. Predicted to be involved in several processes, including histone lysine methylation; meiosis I; and positive regulation of histone methylation. Predicted to act upstream of or within several processes, including histone methylation; meiotic gene conversion; and positive regulation of meiosis I. Predicted to be located in chromatin. Predicted to be active in nucleus. Orthologous to several human genes including PRDM9 (PR/SET domain 9). [provided by Alliance of Genome Resources, Apr 2022]
Prdm9 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001108903.2 | NP_001102373.2 | histone-lysine N-methyltransferase PRDM9 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
histone-lysine N-methyltransferase PRDM9 |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-114209 | MRK-740 | Inhibitor | 99.13% | Unkown |
| HY-RS11073 | PRDM9 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-176820 | MRK-740-NC | Inhibitor | / | Unkown |
| HY-RS19230 | Prdm9 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS25719 | Prdm9 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service